Dongwon F&B 'CoQ10D', New Microparticle Technology... Omega-3 Bioavailability Increased by 610%

[Asia Economy Reporter Seungjin Lee] Dongwon F&B recently launched ‘GNC Aquacell Omega-3 CoQ10 D,’ a product that applies Australia’s biotech company Pharmaco’s ‘Aquacell’ technology for the first time in Korea to enhance the absorption rate of omega-3 fatty acids in the body.

The Aquacell technology breaks down fatty acids, which are poorly soluble in water, into fine microparticles to facilitate easier absorption in the body. When fatty acids are broken down into tiny molecular sizes, the surface area interacting with digestive enzymes increases, making decomposition easier and improving absorption rate and bioavailability. According to clinical trial results, omega-3 products using Aquacell technology have a 610% higher absorption rate of DHA and EPA within 24 hours after intake compared to typical EE form (ethyl ester form where fatty acids are bound to ethanol) omega-3 products.

The main nutritional components of GNC Aquacell Omega-3 CoQ10 D are omega-3, with DHA and EPA content reaching 600 mg. In addition to omega-3, it is a complex functional product containing coenzyme Q10, recognized for its antioxidant properties and blood pressure reduction effects, and vitamin D, which may be deficient during indoor winter living. Especially, taking coenzyme Q10 together with omega-3 can simultaneously manage blood pressure and blood circulation, providing greater support for vascular health.

GNC Aquacell Omega-3 CoQ10 D reduces the characteristic odor often experienced when taking omega-3 products by adding lime, coconut oil, and other ingredients. The capsule size is small for easy swallowing, and the PTP individual packaging ensures safety and hygiene. The product contains 60 capsules of 620 mg each, and the regular price is 69,000 KRW.

This content was produced with the assistance of AI translation services.